USA Equities Corp (OTCMKTS:USAQ) has officially announced on April 19, 2022, the change of its name to QHSLab, Inc. after receiving FINRA approval. This comes at a thrilling moment of growth for the company that offers digital health solutions and point of care diagnostic tests to primary care physicians.
Market Reaction
On Tuesday, USAQ stock gained 19% to $0.4749 with more than 810 shares, compared to its average volume of 940 shares. The stock moved within a range of $0.4000 – 0.4749 after opening trade at $0.40.
The company’s flagship product, QHSLab, has carved a niche for itself and after reviewing strong 2021 earnings, company leadership decided to make QHSLab, Inc. the company’s name. This is a medical device technology company focused on enabling primary care physicians (PCPs) to increase their revenues by providing, value-based tools to evaluate and treat chronic disease through reimbursable procedures.
Troy Grogan, President and CEO of QHSLab, Inc. commented that the name change is a natural step in the expansion process, and represents the strength of their brand. They are focused on building product portfolio so making the name change from USA Equities Corp. to QHSLab, Inc. was the logical step.
QHSLab, Inc. will continue to be led by a group of concerned doctors, academics, health professionals, informatics, and information technology professionals. The mission is still the same – equipping individuals with physician-directed digital medicine and innovative, AI-enhanced, preventive health technologies, so they can take control of their health.
Key Quote
“Our name change is a natural step in the growth process for our company and signals the strength of our brand. QHSLab’s brand name and recognition has continued to gain strength since we launched our platform. We are expanding our product portfolio so making the name change from USA Equities Corp. to QHSLab, Inc. was a fairly straightforward decision,” said Troy Grogan, President and CEO of QHSLab, Inc. “We’re thrilled with the progress we made in 2021 and have continued momentum through Q1 launching new digital products to our physician client base this year,” concluded Grogan.
Traders Review
USAQ stock is trading below the 20-Day and 50-Day Moving averages of $0.51 and $0.54 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.68.
